Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 63629-1975

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 63629-1975). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Image 01)

Figure-1 (Image 01)
This is a table displaying mean plasma concentrations of Dextro and Levoamphetamine measured in ngint. The table shows plasma concentrations at different time points (0, 4, 8, 12, 16, 20, 24) for both types of amphetamines. The text also includes some misspelled drug names under each type of amphetamine.*
FDA Label Image

Label (Lbl636291975)

Label (Lbl636291975)
This is a description of a medication called NILD that comes in extended-release capsules. The capsules contain a mix of amphetamine sulfate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and dextroamphetamine saccharate. The medication should be kept out of reach of children, stored at controlled room temperature, and dispensed in a tightly sealed, light-resistant container with a child-resistant closure. The NDC number is 63629-1975-1 and the medication is only available with a prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.